Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B S Roden

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Cancer Research|July 5, 2006
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cellsRongcun Yang, Zhong Cai, Yuan Zhang, et al.
Journal of Virology|January 21, 2021
EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVOFrank Stubenrauch, Elke Straub, Katrin Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatmentZhenhua Lin, Martina Bazzaro, Mei-Cheng Wang, et al.
The Laryngoscope|September 24, 2017
The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosisJulie Ahn, Justin A Bishop, Richard B S Roden, et al.
Virology Journal|September 13, 2015
Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approachWai-Hong Wu, Tanwee Alkutkar, Balasubramanyan Karanam, et al.
Mbio|June 29, 2023
Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation <i>in vivo</i>Franziska Kuehner, Margaret Wong, Elke Straub, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 10, 2014
Immunoprevention of human papillomavirus-associated malignanciesJoshua W Wang, Chein-Fu Hung, Warner K Huh, et al.
Biometrics|August 22, 2020
A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studiesChenguang Wang, Zhixin Wang, Gary L Rosner, et al.
Virology|January 15, 2014
Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studiesJoshua W Wang, Subhashini Jagu, Kihyuck Kwak, et al.
Cancer Immunology Research|November 22, 2015
Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence-Coupled Biopanning PlatformKathryn M Frietze, Richard B S Roden, Ji-Hyun Lee, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Cancer Research|July 5, 2006
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cellsRongcun Yang, Zhong Cai, Yuan Zhang, et al.
Journal of Virology|January 21, 2021
EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVOFrank Stubenrauch, Elke Straub, Katrin Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatmentZhenhua Lin, Martina Bazzaro, Mei-Cheng Wang, et al.
The Laryngoscope|September 24, 2017
The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosisJulie Ahn, Justin A Bishop, Richard B S Roden, et al.
Virology Journal|September 13, 2015
Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approachWai-Hong Wu, Tanwee Alkutkar, Balasubramanyan Karanam, et al.
Mbio|June 29, 2023
Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation <i>in vivo</i>Franziska Kuehner, Margaret Wong, Elke Straub, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 10, 2014
Immunoprevention of human papillomavirus-associated malignanciesJoshua W Wang, Chein-Fu Hung, Warner K Huh, et al.
Biometrics|August 22, 2020
A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studiesChenguang Wang, Zhixin Wang, Gary L Rosner, et al.
Virology|January 15, 2014
Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studiesJoshua W Wang, Subhashini Jagu, Kihyuck Kwak, et al.
Cancer Immunology Research|November 22, 2015
Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence-Coupled Biopanning PlatformKathryn M Frietze, Richard B S Roden, Ji-Hyun Lee, et al.
Pageof 14